1997
DOI: 10.7326/0003-4819-127-8_part_1-199710150-00028
|View full text |Cite
|
Sign up to set email alerts
|

Over-the-Counter Chromium and Renal Failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2001
2001
2012
2012

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 10 publications
(3 citation statements)
references
References 0 publications
0
3
0
Order By: Relevance
“…Renal biopsy revealed severe, chronic active interstitial nephritis consistent with heavy metal exposure. 15 The second patient developed toxicities similar to those described with hexavalent chromium toxicity (thrombocytopenia, toxic hepatitis, renal failure) after being exposed to chromium 1200 -2400 µg/day for 4 -5 months and was using the supplement at the time of presentation. Hemodialysis was effective for chromium removal.…”
Section: Discussionmentioning
confidence: 81%
See 1 more Smart Citation
“…Renal biopsy revealed severe, chronic active interstitial nephritis consistent with heavy metal exposure. 15 The second patient developed toxicities similar to those described with hexavalent chromium toxicity (thrombocytopenia, toxic hepatitis, renal failure) after being exposed to chromium 1200 -2400 µg/day for 4 -5 months and was using the supplement at the time of presentation. Hemodialysis was effective for chromium removal.…”
Section: Discussionmentioning
confidence: 81%
“…Serum creatinine and blood urea nitrogen were 4.1 mg/dL (0.5-1.4) and 28 mg/dL (7)(8)(9)(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24)(25), respectively. Serum albumin, calcium, and phosphorus levels were 4.9 g/dL (3.7-5.1), 9 mg/dL (8.5-10.4), and 6.7 mg/dL (2.5-4.5), respectively.…”
mentioning
confidence: 99%
“…In addition, a number of literature reviews on the safety and efficacy of chromium picolinate and other trivalent chromium supplements have been published. There are several case studies, clinical studies and volunteer studies performed with chromium picolinate reporting different kind of effects, but these are not suitable for safety assessment (Wasser et al, 1997;Mennen, 1997;Michenfelder et al, 1997;Cerulli et al, 1998;Martin and Fuller, 1998;Kato et al, 1998;Campbell et al, 1997;Pittler et al, 2003;Jeejeebhoy 1999;Anderson, 1997;Lamson and Plaza, 2002;Yeh et al, 2003;Finch et al, 2004;IOM, 2004). Points of concern, in a few case studies, were possible impairment of the kidney function and rhabdomyolysis, although due to pivotal confounding factors these studies were not conclusive.…”
Section: Human Studiesmentioning
confidence: 99%